BB Biotech Stock Forward View - Triple Exponential Smoothing
| BION Stock | CHF 46.70 0.35 0.74% |
BION Stock outlook is based on your current time horizon.
At this time, The RSI of BB Biotech's share price is at 53 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling BB Biotech, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.46) | EPS Estimate Current Year 9.82 | EPS Estimate Next Year 4.91 | Wall Street Target Price 47.7 | Quarterly Revenue Growth 11.406 |
Using BB Biotech hype-based prediction, you can estimate the value of BB Biotech AG from the perspective of BB Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Triple Exponential Smoothing forecasted value of BB Biotech AG on the next trading day is expected to be 46.69 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 38.13. BB Biotech after-hype prediction price | CHF 46.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BION |
BB Biotech Additional Predictive Modules
Most predictive techniques to examine BION price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BION using various technical indicators. When you analyze BION charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BB Biotech Triple Exponential Smoothing Price Forecast For the 3rd of February
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of BB Biotech AG on the next trading day is expected to be 46.69 with a mean absolute deviation of 0.65, mean absolute percentage error of 0.69, and the sum of the absolute errors of 38.13.Please note that although there have been many attempts to predict BION Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BB Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BB Biotech Stock Forecast Pattern
| Backtest BB Biotech | BB Biotech Price Prediction | Research Analysis |
BB Biotech Forecasted Value
In the context of forecasting BB Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BB Biotech's downside and upside margins for the forecasting period are 44.96 and 48.43, respectively. We have considered BB Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BB Biotech stock data series using in forecasting. Note that when a statistical model is used to represent BB Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0934 |
| MAD | Mean absolute deviation | 0.6462 |
| MAPE | Mean absolute percentage error | 0.0143 |
| SAE | Sum of the absolute errors | 38.1276 |
Predictive Modules for BB Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BB Biotech AG. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BB Biotech After-Hype Price Density Analysis
As far as predicting the price of BB Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BB Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BB Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BB Biotech Estimiated After-Hype Price Volatility
In the context of predicting BB Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BB Biotech's historical news coverage. BB Biotech's after-hype downside and upside margins for the prediction period are 45.06 and 48.54, respectively. We have considered BB Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BB Biotech is very steady at this time. Analysis and calculation of next after-hype price of BB Biotech AG is based on 3 months time horizon.
BB Biotech Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as BB Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BB Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BB Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 1.74 | 0.10 | 0.01 | 1 Events / Month | 2 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
46.70 | 46.80 | 0.21 |
|
BB Biotech Hype Timeline
BB Biotech AG is currently traded for 46.70on SIX Swiss Exchange of Switzerland. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of -0.01. BION is anticipated to increase in value after the next headline, with the price projected to jump to 46.8 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is anticipated to be 0.21%, whereas the daily expected return is currently at 0.23%. The volatility of related hype on BB Biotech is about 7421.8%, with the expected price after the next announcement by competition of 46.69. The company reported the revenue of 111.63 M. Net Income was 75.9 M with profit before overhead, payroll, taxes, and interest of 201.41 M. Assuming the 90 days trading horizon the next anticipated press release will be very soon. Check out Historical Fundamental Analysis of BB Biotech to cross-verify your projections.BB Biotech Related Hype Analysis
Having access to credible news sources related to BB Biotech's direct competition is more important than ever and may enhance your ability to predict BB Biotech's future price movements. Getting to know how BB Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BB Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IDIA | Idorsia | 0.07 | 6 per month | 3.46 | 0.02 | 7.12 | (6.39) | 22.30 | |
| TECN | Tecan Group AG | 0.1 | 6 per month | 0.00 | (0.09) | 4.05 | (3.61) | 12.91 | |
| KURN | Kuros Biosciences AG | 0.16 | 4 per month | 0.00 | (0.11) | 5.38 | (3.69) | 14.60 | |
| BSLN | Basilea Pharmaceutica AG | 0.30 | 3 per month | 1.61 | 0.07 | 3.01 | (2.58) | 10.08 | |
| EVE | Evolva Holding SA | (0.04) | 5 per month | 3.74 | 0.01 | 8.00 | (7.14) | 26.00 | |
| SANN | Santhera Pharmaceuticals Holding | (0.24) | 3 per month | 2.21 | 0.11 | 5.79 | (4.47) | 18.95 | |
| MOLN | Molecular Partners AG | (0.11) | 7 per month | 3.26 | 0.07 | 7.50 | (5.28) | 22.81 | |
| ADXN | Addex Therapeutics | (0) | 10 per month | 0.00 | (0.11) | 5.28 | (6.90) | 17.23 | |
| NWRN | Newron Pharmaceuticals SpA | (0.45) | 4 per month | 2.89 | 0.12 | 6.92 | (5.30) | 21.18 |
Other Forecasting Options for BB Biotech
For every potential investor in BION, whether a beginner or expert, BB Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BION Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BION. Basic forecasting techniques help filter out the noise by identifying BB Biotech's price trends.BB Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BB Biotech stock to make a market-neutral strategy. Peer analysis of BB Biotech could also be used in its relative valuation, which is a method of valuing BB Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BB Biotech Market Strength Events
Market strength indicators help investors to evaluate how BB Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BB Biotech shares will generate the highest return on investment. By undertsting and applying BB Biotech stock market strength indicators, traders can identify BB Biotech AG entry and exit signals to maximize returns.
BB Biotech Risk Indicators
The analysis of BB Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BB Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.52 | |||
| Standard Deviation | 1.76 | |||
| Variance | 3.09 | |||
| Downside Variance | 3.27 | |||
| Semi Variance | 2.32 | |||
| Expected Short fall | (1.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BB Biotech
The number of cover stories for BB Biotech depends on current market conditions and BB Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BB Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BB Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
BB Biotech Short Properties
BB Biotech's future price predictability will typically decrease when BB Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BB Biotech AG often depends not only on the future outlook of the potential BB Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BB Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.8 M | |
| Cash And Short Term Investments | 2.4 B |
Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.